Sristi Biosciences Pvt Ltd Hyderabad, Telangana

Sristi Biosciences Private Limited is a next generation biosciences company that focuses on the converging healthcare value chain. The business opportunity of Sristi is mapped out of carefully evolved opportunity selection criteria that consider market transition, size, sustainability and uniqueness. Transition of Healthcare industry globally shows a common trend of disease migration form infectious diseases to life style associated conditions. Arthritis, diabetes, cardiac disorders, respiratory problems, cancer and CNS play a major role today as against infectious diseases. Sristi’s approach to this transition takes a life cycle approach of the patient. PREVENT, CURE, REGENERATE is the concept evolved, which aligns healthcare approach against patient life cycle. Early incidence of arthritis, diabetes and cardiac disorders motivates the system to critically analyse ‘Prevent’ approaches to healthcare, where in Sristi brings together all its experience traditional system of medicine and scientific new generation evidences together for a clear business model. Our natural Product division is a result of this approach, where innovation is focused on reaching a common man with healthcare solution effortlessly without disturbibg their routine. Middle age and late stage life cycle challenges are associated with ‘Cure’. Drug discovery approach through natural products is the second approach, considering the value of reverse pharmacology and the ability of natural sources to pipeline new drugs. By age, degeneration leads to most life style problems that include arthritis, spondylitis, liver disorders, cardiac, etc. Tissue regeneration and transplantation is the third approach to healthcare planned as part of Sristi. The company is in the business of servicing healthcare and pharmaceutical research globally using the core strengths of Sristi’s background. Business focus of Sristi is to develop research products and services that ensure healthcare R&D productivity and efficiency. The company develops and manages knowledge and service infrastructure to serve clients who require drug discovery, screening, therapy and new product development support. In technical terms, the company offer new drug screening services by maintaining novel compound libraries and cell lines. In addition the company develop and license out formulations for pharmaceuticals, cosmeceuticals and nutraceutical companies. The company also markets its own OTC brands as health supplements as a value added revenue opportunity. The company has three major division established that together meet the primary objective of the company. Natural Products division– Natural products division has three major areas of operation. Supply of compounds for screening, licensing new formulation and OTC are the three areas of business focus. Cell Products Division– Cell products division partnered with one of world’s leading cell products company Lifeline Cell Technology for distributing cell products. This division supply cell lines for compound screening. In addition the division also focuses on therapeutic development of Autologous Chondrocyte Implantation. The company also evaluates marker products and RNA based products for extending the research products portfolio. Discovery Services Division– This division integrates the strengths of other two division and evolve a promising turn key discovery solution for big pharma clients. Sristibio is unique by its approach to healthcare research; We bring together traditional wisdom and technological advancements for adding value to quality of life We believe in the principles of evolution, nature and systems biology that generates sustained healthcare value. Our values drive a medically aware society.